#Drug Development

1 articles

A laboratory setting showing a double-helix DNA strand being adjusted by a robotic arm, with a glowi

Biotech’s Cross-Border Evolution: From GLP-1 Partnerships to Age-Reversal Research

The biotech industry is seeing increased cross-border collaboration, with progress in GLP-1 obesity treatments and innovations in cellular reprogramming and drug delivery driving global advancements in medical science.

Williams·Jun 12, 2026·2 min read

#Drug Development | Seges Intelligence